Skip to main content
SpringerLink
Log in

Aphthen und Morbus Behçet

  • Chapter
Therapie der Hautkrankheiten

  • 91 Accesses

Zusammenfassung

Aphthen sind solitäre, meist aber in der Mehrzahl auftretende, schmerzhafte, linsen- bis über 10 mm große, entzündliche Ulzerationen der oralen bzw. genitalen Schleimhaut. Sie sind von einer Fibrinmembran bedeckt und von einem hyperämischen Hof umgeben, entstehen rasch, rezidivieren häufig und können über mehrere Jahre bestehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Boisnic S, Tovaru S (1991) Bilan et traitément des aph- toses buccales. Ann Dermatol Venereol 118: 53–59

    PubMed  CAS  Google Scholar 

  • Bork K (1987) Differentialdiagnose und Therapie der rezidivierenden Aphthen. Z Hautkr 62: 845–849

    PubMed  CAS  Google Scholar 

  • Chadwick B, Addy M, Walker DM (1991) Hexetidine mouthrinse in the management of minor aphthous ulceration and as an adjunct to oral hygiene. Br Dent J 171: 83–87

    Article  PubMed  CAS  Google Scholar 

  • Collier PM, Neill SM, Copeman PWM (1992) Topical 5-aminosalicylic acid: a treatment for aphthous ulcers. Br J Dermatol 126: 185–188

    Article  PubMed  CAS  Google Scholar 

  • Denman AR, Schiff AA (1979) Treatment of reccurent aphthous ulceration of the oral cavity. Br Med J 1: 1248–1249

    Article  PubMed  CAS  Google Scholar 

  • Drinnan AJ, Fischman SL (1978) Randomized, double-blind study of levamisole in recurrent aphthous stomatitis. J Oral Pathol 7: 414–417

    Article  PubMed  CAS  Google Scholar 

  • Eisen D, Ellis CN (1990) Topical cyclosporine for oral mucosal disorders. J Am Acad Dermatol 23: 1259–1264

    Article  PubMed  CAS  Google Scholar 

  • Gatot A, Tovi F (1984) Colchicine therapy in recurrent oral ulcers (letter). Arch Dermatol 120: 994

    Article  PubMed  CAS  Google Scholar 

  • Genvo MF, Faure M, Thivolet J (1984) Traitément de l’aphtose par la thalidomide et la colchicine. Dermatologica 168: 182–188

    Article  PubMed  CAS  Google Scholar 

  • Ghigliotti G, Repetto T, Farris A et al. (1993) Thalidomide: Treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus. J Am Acad Dermatol 28: 271–272

    Article  PubMed  CAS  Google Scholar 

  • Graykowski EA, Kingman A (1978) Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol 7: 376–382

    Article  PubMed  CAS  Google Scholar 

  • Greer RO Jr, Lindenmuth JE, Juarez T, Khandwala A (1993) A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Macillofac Surg 51: 243–249

    Article  Google Scholar 

  • Grinspan D, Fernandez Blanco G, Agüero S (1989) Treatment of aphthae with thalidomide. J Am Acad Dermatol 20: 1060–1063

    Article  PubMed  CAS  Google Scholar 

  • Handfield-Jones S, Allen BR, Littlewood SM (1985) Dapsone use with oral-genital ulcers (letter). Br J Dermatol 113: 501

    Article  PubMed  CAS  Google Scholar 

  • Hay D, Reade PC (1984) The use of an elimination diet in the treatment of recurrent aphthous ulceration of the oral cavity. Oral Surg Oral Med Oral Pathol 57: 504–507

    Article  PubMed  CAS  Google Scholar 

  • Hunter L, Addy M (1987) Chlorhexidine gluconate mouthwash in the management of minor aphthous stomatitis. Br Dent J 162: 106–110

    Article  PubMed  CAS  Google Scholar 

  • Jenkins JS, Powell RJ, Allen BR, Littlewood SM, Maurice PDL, Smith NJ (1984) Thalidomide in severe orogenital ulceration. Lancet II: 1424–1426

    Article  Google Scholar 

  • Kaplan B, Cardarelli C, Pinnell SR (1978) Double-blind study of levamisole in aphthous stomatitis. J Oral Pathol 7: 400–404

    Article  PubMed  CAS  Google Scholar 

  • Mascaro JM, Lecha M, Torras H (1979) Thalidomide in the treatment of recurrent, necrotic and giant muco-cutaneous aphthae and aphthosis. Arch Dermatol 115: 636–637

    Article  PubMed  CAS  Google Scholar 

  • Matthews RW, Scully CM, Levers BGH, Hislop WS (1987) Clinical evaluation of benzylamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 63: 189–191

    Article  PubMed  CAS  Google Scholar 

  • Miller ME Silvert ME, Laster LL, Green P, Ship II (1978) Effect of levamisole on the incidence and prevalence of recurrent aphthous stomatitis: a double-blind clinical trial. J Oral Pathol 7: 387–392

    Article  Google Scholar 

  • Misra R, Anderson DC (1989) Treatment of recurrent premenstrual orogenital aphthae with implants of low doses of testosterone. Br J Med 299: 834

    Article  CAS  Google Scholar 

  • Murphy GM, Griffiths WAD (1989) Aphthous ulcers responding to etretinate–a case report. Clin Exp Dermatol 14: 330–331

    Article  PubMed  CAS  Google Scholar 

  • Olson JA, Silverman S (1978) Double-blind study of levamisole therapy in recurrent aphthous stomatitis. J Oral Pathol 7: 793–399

    Article  Google Scholar 

  • Porter SR, Scully C (1991) Aphthous stomatitis–an overview of aetiopathogenesis and management. Clin Exp Dermatol 16: 235–243

    Article  PubMed  CAS  Google Scholar 

  • Revuz J, Guillaume J-C, Janier M et al. (1990) Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 126: 923–927

    Article  PubMed  CAS  Google Scholar 

  • Ruah CB, Stram JR, Chasin WD (1988) Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg 114: 671–675

    Article  PubMed  CAS  Google Scholar 

  • Schulkind ML, Heim LR, South MA, Jeter WS, Small PA (1984) A case report of the successful treatment of recurrent aphthous stomatitis with some preparations of orally administered transfer factor. Cell Immunol 84: 415–421

    Article  PubMed  CAS  Google Scholar 

  • Taylor LJ, Walker DM, Bagg JA (1993) Clinical trial of prostaglandin E2 in recurrent aphthous ulceration. Br Dent J 175: 125–129

    Article  PubMed  CAS  Google Scholar 

  • Thompson AC, Nolan A, Lamey PJ (1989) Minor aphthous oral ulceration: a double-blind cross-over study of beclomethsone dipropionate aerosol spray. Scott Med J 34: 531–532

    PubMed  CAS  Google Scholar 

  • Wormser GP, Mack L, Lenox T et al. (1988) Lack of effect of oral acyclovir on prevention of aphthous stomatitis. Otolaryngol Head Neck Surg 98: 14–17

    PubMed  CAS  Google Scholar 

  • Aktulga A, Altac M, Muftuoglu AU et al. (1980) A double blind study of colchicine in Behçet’s disease. Haematologica 65: 399–402

    PubMed  CAS  Google Scholar 

  • Ammann AJ, Johnson A, Fyfe GA, Leonards R, Wara DW, Cowan MJ (1985) Behçet’s syndrome. J Pediatr 107: 41–43

    Article  PubMed  CAS  Google Scholar 

  • Arbesfeld SJ, Kurban AK (1988) Behçet’s disease. New perspectives on an enigmatic syndrome. J Am Acad Dermatol 19: 767–779

    Article  PubMed  CAS  Google Scholar 

  • Davies UM, Palmer RG, Denman AM (1988) Treatment with acyclovir does not affect orogenital ulcers in Behçet’s syndrome: a randomized double-blind trial. Br J Rheumatol 27: 300–302

    Article  PubMed  CAS  Google Scholar 

  • Diaz-Llopis M, Cervera M, Menezo JL (1990) Cyclosporin treatment of Behçet’s disease: a long-term study. Curr Eye Res 9 [Suppl]: 17–23

    Article  PubMed  Google Scholar 

  • Dührsen U, Kirch W (1985) Therapie des Behçet-Syndroms. Dtsch Med Wochenschr 110: 267–270

    Article  PubMed  Google Scholar 

  • Elidan J, Levi H, Cohen E, BenEzra D (1991) Effect of cyclosporine A on the hearing loss in Behçet’s disease. Ann Otol Rhinol Laryngol 100: 464–468

    PubMed  CAS  Google Scholar 

  • Fierlbeck G, Rassner G (1990) Morbus Behçet: Therapie mit rekombinantem Interferon gamma. Akt Dermatol 16: 226–230

    Google Scholar 

  • Hamuryudan V, Yurdakul S, Rosenkaimer F, Yazici H (1991) Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet’s syndrome: a randomized, double blind trial. Br J Rheumatol 30: 395–396

    Article  PubMed  CAS  Google Scholar 

  • Du LT, Fain O, Wechsler B et al. (1990) Intérêt des „bolus“ de cyclophosphamide dans la maladie de Behçet. Expérience de 17 cas. Presse Med 19: 1355–1358

    PubMed  CAS  Google Scholar 

  • Hamza M, Meddeb S, Mili I, Ouertani A (1992) Les bolus de cyclophosphamide et de methylprednisolone dans l’uveite de la maladie de Behçet. Resultats preliminaires comportant l’utilisation de nouveaux criteres d’evaluation. Ann Med Interne (Paris) 143: 438–441

    CAS  Google Scholar 

  • International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078–1080

    Google Scholar 

  • Jaimovich L (1992) Tratamiento del sindrome de Behçet. Med Cutan Ibero Lat Am 20: 31–35

    Google Scholar 

  • Jorizzo JL, White WL, Wise CM et al. (1991) Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarterütis nodosa and Behçet’s disease. J Am Acad Dermatol 24: 973–978

    Article  PubMed  CAS  Google Scholar 

  • Lambert D, Rifle G, Guiod-Deschamps I, Collet E (1990) Plasma exchange in patients with Behçet’s disease (letter). J Am Acad Dermatol 22: 1123

    Article  PubMed  CAS  Google Scholar 

  • Larson H (1990) Treatment of severe colitis in Behçet’s syndrome with thalidomide. J Intern Med 228: 405–407

    Article  Google Scholar 

  • Margolis DJ, Guzzo C, Johnson J, Lazarus GS (1992) Alterations in renal function in psoriasis patients with cyclosporine, 5 mg/kg/day. J Am Acad Dermatol 26: 195–197

    Article  PubMed  CAS  Google Scholar 

  • Masuda K, Urayama A, Kogure M et al. (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s disease. Lancet I: 1093–1096

    Article  Google Scholar 

  • Nussenblatt RB (1988) The use of cyclosporin in ocular inflammatory disorder. Transplant Proc 20 [Suppl 4] 114–121

    PubMed  CAS  Google Scholar 

  • O’Duffy JD, Robertson DM, Goldstein NP (1984) Chlorambucil in the treatment of uveitis and meningoenzephalitis of Behçet’s disease. Am J Med 76: 75–84

    Article  PubMed  Google Scholar 

  • Prieto J, Suarez J, Civeira P (1984) Acyclovir in Behçet’s disease. Ann Intern Med 101: 565–566

    PubMed  CAS  Google Scholar 

  • Sharquie KE (1984) Suppression of Behçet’s disease with dapsone. Br J Dermatol 110: 493–494

    Article  PubMed  CAS  Google Scholar 

  • Simsek H, Dundar S, Telatar H (1991) Treatment of Behçet’s disease with indomethacin. Int J Dermatol 30: 54–57

    Article  PubMed  CAS  Google Scholar 

  • Stadler R, Bratzke B, Orfanos CE (1987) Therapeutischer Einsatz von alpha-Interferon bei metastasierendem malignen Melanom, disseminiertem KaposiSarkom und schwerem Morbus Behçet. Hautarzt 38: 453–460

    PubMed  CAS  Google Scholar 

  • Takeuschi A, Hashimoto T (1988) Oral prostaglandin El as a therapeutic modality for leg ulcers in Behçet’s disease. Int J Clin Pharmacol Res 7: 283–289

    Google Scholar 

  • Torras H, Lecha M, Mascaró JM (1982) La talidomida en el tratamiento de las aftosis y enfermedad de Behçet. Experiencia de cuatro anos. Med Cutan Ibero Lat Am 10: 103–112

    PubMed  CAS  Google Scholar 

  • Tsambaos D, Eichelberg D, Goos M (1986) Behçet’s syndrome: treatment with recombinant leucocyte alpha-interferon. Arch Dermatol Res 278: 335–336

    Article  PubMed  CAS  Google Scholar 

  • Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behçet’s syndrome. Drugs 42: 796–804

    Article  PubMed  CAS  Google Scholar 

  • Yazici H, Pazarli H, Barnes CG et al. (1990) A controlled trial of azathioprin in Behçet’s syndrome. N Engl J Med 322: 281–285

    Article  PubMed  CAS  Google Scholar 

  • Zouboulis ChC, Büttner P, Djawari D et al. (1993) HLA-Muster bei Morbus Adamantiades-Behçet in Deutschland: Assoziation zum Auftreten, der klinischen Symptomatik und dem Krankheitsverlauf bei 39 Patienten. Hautarzt 44: 81–85

    PubMed  CAS  Google Scholar 

  • Zouboulis ChC, Treudler R, Orfanos CE (1993) Morbus Adamantiades-Behçet: therapeutischer Einsatz von systemischen rekombinantem Interferon-alpha2a. Hautarzt 44: 440–445

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Hautklinik und Poliklinik, Klinikum Benjamin Franklin der Freien Universität Berlin, Hindenburgdamm 30, 12200, Berlin, Deutschland

    Prof. Dr. Prof. h.c. Constantin E. Orfanos & Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h.c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (1995). Aphthen und Morbus Behçet. In: Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97602-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97602-5_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97603-2

  • Online ISBN: 978-3-642-97602-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation